Inovio Pharmaceuticals In... (INO)
The price, the headline numbers and the latest news, in one place.
Inovio Pharmaceuticals Inc. (INO) Stock Price, Analysis & Data
| Bid | 1.09 |
| Market Cap | 134.42M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -67.43M |
| 1.51 | |
| -1.03 | |
| n/a | |
| -2.95 | |
| P/B (ttm) | 24.53 |
| P/S (ttm) | n/a |
| Earnings Date | Nov 10, 2026 |
| Ask | 1.46 |
| Volume | 3,599,343 |
| Avg. Volume (20D) | 3,223,927 |
| Open | 1.25 |
| Previous Close | 1.25 |
| Day's Range | 1.24 - 1.30 |
| 52-Week Range | 0.56 - 2.98 |
| Analyst | Buy |
| Price Target | 3 (132.56%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About INO
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The com...
Financial Performance
In 2025, Inovio Pharmaceuticals's revenue was 65.34K, a decrease of -69.99% compared to the previous year's 217.76K. Earnings were -84.95M, a decrease of -20.8%.
Financial StatementsAnalyst Forecast
According to 3 analyst ratings, the average rating for INO stock is "Buy". The 12-month stock price forecast is 3, which is upside of 132.56% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $0 misses estimates by $0, with -100.00% YoY decline.
- EPS of -0.24 misses estimates by 0.00, with 60.66% YoY growth.
Analysts project revenue of ... Upgrade
